Prognostic significance of microvessel density and vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma.
about
Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphomaLymphoma: immune evasion strategiesPhase II open label study of the oral vascular endothelial growth factor-receptor inhibitor PTK787/ZK222584 (vatalanib) in adult patients with refractory or relapsed diffuse large B-cell lymphomaAngiogenesis in nodal B cell lymphomas: a high throughput study.A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108.The role of angiogenesis in human non-Hodgkin lymphomas.Strong cross-talk between angiogenesis and EBV: do we need different treatment approaches in lymphoma cases with EBV and/or high angiogenic capacity.Targeting the vascular endothelial growth factor in hematologic malignancies.VEGF overexpression is a valuable prognostic factor for non-Hodgkin's lymphoma evidence from a systemic meta-analysis.Treatment options for mantle cell lymphoma.Temsirolimus in the treatment of relapsed and/or refractory mantle cell lymphoma.Vascularization predicts overall survival and risk of transformation in follicular lymphoma.VEGF and bFGF gene polymorphisms in patients with non-Hodgkin's lymphoma.Angiogenesis in Non-Hodgkin's Lymphoma: An Intercategory Comparison of Microvessel DensityCyclooxygenase-2 (Cox-2) expression in lymphomas.Pretreatment levels of vascular endothelial growth factor in plasma predict a complete remission rate and time to relapse or progression in patients with diffuse large B-cell lymphoma.Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients?The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas.Clinical correlations and prognostic relevance of HGF, VEGF AND FGF expression in Brazilian patients with non-Hodgkin lymphoma.Angiogenesis-related growth factors and cytokines in the serum of patients with B non-Hodgkin lymphoma; relation to clinical features and response to treatment.Vascular endothelial growth factor concentrations from platelets correlate with tumor angiogenesis and grading in a spontaneous canine non-Hodgkin lymphoma model
P2860
Q24633714-12EF0F3F-7C73-465E-99D4-173D928B6D18Q28080705-529DD6B1-9FDA-4B5C-8BBB-006DE1CA4F71Q33406444-46E30360-3762-4BBB-BD82-4DCD3929D1C6Q36014424-29EEA87A-4D82-4266-8691-78A49CC3E366Q36495915-4F20E7AC-839D-48D1-8B28-32C87B8CDE7CQ36670881-66932BFF-4A02-4D9E-8A0E-EBD9986DB3B6Q37938966-6F75EE88-30DC-44A8-9DAD-08E1195101BFQ38038645-7B4EACE1-9F92-4524-A112-2A34B06C79D7Q38391574-D8E99D9D-ABB6-43BC-8477-2110EE31D11AQ38584922-6803E99E-E3F5-40FF-9D61-4F1E4A32FFA2Q41241688-6DAEDC8A-FAE3-4E2E-A582-D0A6E303C366Q41325464-8E7E3CB1-23CD-47AE-A17B-F219BD46AB9AQ41953798-B3BDAEAA-EB6D-4AFA-8302-29933E3E53CEQ42023764-1DF7EF50-81BC-4B1E-834E-0AFF436A9244Q45053419-202CCD07-9F33-4B91-832D-F1AEFC781591Q45849297-BD72CFD7-6FED-4992-85F4-FA4437B52908Q46193990-D2A166A6-2EAC-471B-B833-C4A51942C1EEQ51733952-43421AF5-FC41-49B3-BFCC-1F3DB437FA22Q53221535-0DD0A71D-2237-45B4-B60B-8AE561395CB5Q53222523-8DB36BAF-3EA2-4940-9DD5-103EFCD3B30CQ57530074-F364DCA6-E549-4679-8F0E-76445E851435
P2860
Prognostic significance of microvessel density and vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Prognostic significance of mic ...... ion in non-Hodgkin's lymphoma.
@en
type
label
Prognostic significance of mic ...... ion in non-Hodgkin's lymphoma.
@en
prefLabel
Prognostic significance of mic ...... ion in non-Hodgkin's lymphoma.
@en
P2093
P2860
P1433
P1476
Prognostic significance of mic ...... ion in non-Hodgkin's lymphoma.
@en
P2093
Berksoy Sahin
Burhan Hazar
Ilhan Tuncer
Semra Paydas
Suzan Zorludemir
P2860
P304
P356
10.1080/1042819031000123519
P577
2003-12-01T00:00:00Z